All blog posts
Total 216 results for
Showing 168 out of 216 results
11 September 2019
Updated HSF Legal Guide to Brexit published (including IP and Pharma sections)
11 July 2019
Open Innovation: Collaborate to Innovate
10 July 2019
Patent and Pharma Update – July 2019
10 June 2019
New German Trade Secrets Act Enacted
08 May 2019
Data Assets - Protecting and Driving Value in a Digital Age
05 April 2019
Patent and Pharma Update - April 2019
28 March 2019
Supreme Court upholds Court of Appeal's finding of obviousness in relation to a patented dosage regime
25 March 2019
The Court of Justice of the European Union holds that Supplementary Protection Certificates cannot be obtained for new formulations of previously approved active ingredients in Abraxis (Case C-443/17)
06 February 2019
Herbert Smith Freehills' global Trade Marks Practice lauded a 'formidable force' in WTR 1000 rankings
14 January 2019
Herbert Smith Freehills' Brexit Legal Guide updated - comparison of IP and pharma provisions in the draft Withdrawal Agreement versus the No Deal provisions promised by the UK Government
20 December 2018
Preparations for the UPC continue despite an "unpredictable environment"
The UPC Preparatory Committee has issued a “Status of the Unified Patent Court Project” statement and review of 2018, confirming that there …
14 December 2018
Advocate General proposes literal interpretation of Article 3(d) SPC Regulation in Abraxis (C-443/17)
The Advocate General of the CJEU proposed a narrow interpretation of Article 3(d) in the Opinion given yesterday in Abraxis …
Showing 168 out of 216 results
View more